Immunological non-inferiority and safety of a quadrivalent inactivated influenza vaccine versus two trivalent inactivated influenza vaccines in China: Results from two studies

A quadrivalent, split-virion influenza vaccine (Shz QIV), containing two influenza A strains, and both B lineages strains, has been developed in China. We report the safety and immunogenicity of Shz QIV in two studies: a single-center, phase I, open-label, safety trial (n = 101) and a multicenter, p...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Xiaoqiang, Park, Juliana, Xia, Shengli, Liang, Bin, Yang, Shuangmin, Wang, Yanxia, Syrkina, Olga, Lavis, Nathalie, Liu, Shuzhen, Zhao, Chenyan, Ding, Jian, Hu, Jieqiong, Samson, Sandrine I., de Bruijn, Iris A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2022
Materias:
Influenza – Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9746500/
https://www.ncbi.nlm.nih.gov/pubmed/36328438
http://dx.doi.org/10.1080/21645515.2022.2132798

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9746500/
https://www.ncbi.nlm.nih.gov/pubmed/36328438
http://dx.doi.org/10.1080/21645515.2022.2132798

Ejemplares similares